ArticleBMC cancer2019

Opinions and use of neoadjuvant therapy for resectable, borderline resectable, and locally advanced pancreatic cancer: international survey and case-vignette study.

Stefan Heinrich et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.